AYTU BIOPHARMA, INC Long-term Debt and Lease Obligation
AYTU BIOPHARMA, INC (AYTU) had Long-term Debt and Lease Obligation of $9.10 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation
us-gaap:LongTermDebtAndCapitalLeaseObligations · last filed 2026-09-22
- 2026-06-30: Long-term Debt and Lease Obligation $9.10M.
- 2026-03-31: Long-term Debt and Lease Obligation $9.55M.
- 2025-12-31: Long-term Debt and Lease Obligation $10.00M.
- 2025-09-30: Long-term Debt and Lease Obligation $10.45M.
| Period end | Long-term Debt and Lease Obligation |
|---|---|
| 2026-06-30 | $9.10M 10-K · filed 2026-09-22 |
| 2026-03-31 | $9.55M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $10.00M 10-Q · filed 2026-02-03 |
| 2025-09-30 | $10.45M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $10.89M 10-K · filed 2026-09-22 |
| 2025-03-31 | $9.54M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $9.98M 10-Q · filed 2025-02-12 |
| 2024-09-30 | $10.43M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $10.88M 10-K · filed 2025-09-23 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 |
| 2023-12-31 | $14.98M 10-Q · filed 2024-02-14 |
| 2023-09-30 | $14.84M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $14.71M 10-K · filed 2024-09-26 |
| 2023-03-31 | $11.39M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $14.53M 10-Q · filed 2023-02-21 |
| 2022-09-30 | $13.56M 10-Q/A · filed 2023-02-21 |
| 2022-06-30 | $14.28M 10-K · filed 2023-10-12 |
| 2022-03-31 | $14.17M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $129.00K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $154.00K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $180.00K 10-K · filed 2022-09-27 |
| 2020-06-30 | $0.00 10-K · filed 2021-09-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |